SMS Pharmaceuticals Limited has informed the Exchange about General Updates
SMSPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
SMS Pharmaceuticals has received approval from BSE and NSE for listing and trading of 40,00,000 new equity shares of face value Re. 1 each, issued at a premium of Rs. 126 per share to the promoter and promoter group. These shares were allotted on a preferential basis following the conversion of warrants, and they will be available for trading on the exchanges from June 18, 2025. The total value of the issue is approximately Rs. 50.8 crore, and the new shares carry a lock-in period until March 30, 2027, meaning promoters cannot sell them before that date.
Existing shareholders will see a modest dilution of about 40 lakh new shares issued to promoters at a healthy premium of Rs. 127, which signals promoter commitment and confidence in the company. Since the shares are locked in until March 2027, there is no immediate supply overhang, which is generally positive for the stock price.